Takeda Pharmaceuticals Marks its 240th Founding Anniversary finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Takeda introduces the In Their Shoes experience to the Middle East in support of the IBD patient community
USA - English
Share this article
DUBAI, UAE, June 9, 2021 /PRNewswire/ Takeda (TSE: 4502) (NYSE: TAK) has introduced the In Their Shoes platform, an award-winning, immersive simulation program to promote greater awareness and empathy for patients with Inflammatory bowel disease (IBD), a condition to describe Crohn s disease and ulcerative colitis, to a group of healthcare providers in the Middle East the first time.
The subscription-based program launched with a two-day simulation where healthcare providers and Takeda employees learned about the condition most effectively and profoundly: by living with it.
Takeda’s dengue vaccine candidate suggest that it could help with outbreak prevention REPUBLIKA.CO.ID, JAKARTA Takeda Pharmaceutical Company Limited (Takeda) announced that its dengue vaccine candidate (TAK-003) demonstrated continued protection against dengue illness and hospitalization, regardless of an individual s previous dengue exposure, with no important safety risks identified through three years after vaccination in the ongoing pivotal Phase 3 Tetravalent Immunization against Dengue Efficacy Study (TIDES) trial. TIDES enrolled more than 20.000 healthy children and adolescents ages four to 16 years in dengue-endemic countries in Latin America and Asia. Dengue epidemics occur suddenly, and hospitals can become overwhelmed with severe disease cases and people seeking testing, said Managing Director Center for Clinical Management of Dengue and Dengue Haemorrhagic Fever, Negombo General Hospital, Sri Lanka and a primary investigator of the TIDES trial, LakKumar Fernando
Emergency strategy allows businesses to import vaccines Chia sẻ | FaceBookTwitter Email Copy Link Copy link bài viết thành công
03/06/2021 11:17 GMT+7
All businesses, organizations and provinces are allowed to negotiate with suppliers of legal vaccine sources, but they must contact qualified agencies.
Deputy Health Minister Tran Van Thuan said the policy of the Vietnamese Government and the Ministry of Health is to diversify the sources of supply of Covid-19 vaccines to quickly have vaccines for people. Vietnam aims to have 150 million doses by the end of this year.
The Ministry of Health expects that organizations, individuals, businesses, provinces and cities, with their relationships, can connect and access legal and qualified vaccine sources. The Ministry of Health, in its functions and duties, is ready to create favorable conditions for licensing, te
Redirecting to Potential Impact of Takeda s Dengue Vaccine Candidate Reinforced by Long-Term Safety and Efficacy Results q8dailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from q8dailynews.com Daily Mail and Mail on Sunday newspapers.